Acute High Intensity Interval Training and Blood Flow Restriction

Sponsor
Nanyang Technological University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05835544
Collaborator
(none)
24
1
4
16
1.5

Study Details

Study Description

Brief Summary

The study aims to look at the blood flow restriction (BFR) + high intensity interval training (HIIT) variables to induce an optimal acute training stimulus (i.e., acute responses in main outcome measures of muscular activation, muscular deoxygenation, and secondary outcome measures of heart rate (HR), blood lactate (bLa), subjective ratings of perceived exertion and discomfort)

The hypotheses for this study are: (i) BFR increases muscular deoxygenation, muscular activation when HIIT exercise is of the same intensity, (ii) however, comparing between a lower BFR + HIIT exercise intensity (e.g. 80% V̇O2max) and higher HIIT exercise intensity (e.g. 100% V̇O2max), muscular deoxygenation and activation will be similar but HR will be lower in the BFR + HIIT condition.

Condition or Disease Intervention/Treatment Phase
  • Other: Active Comparator: HIIT Control
  • Other: Experimental: HIIT + BFR between cycling sets
  • Other: Experimental: HIIT + BFR moderate occlusion during cycling
  • Other: Experimental: HIIT + BFR high occlusion during cycling
N/A

Detailed Description

This study revolves around the optimisation of blood flow restriction (BFR) and high-intensity interval training (HIIT) protocols for the racket sport athlete. The study aims to look at the BFR + HIIT variables to induce an optimal acute training stimulus. This can be achieved with the consideration of two main research questions: (i) What is the ideal combination of BFR cuff pressure and exercise intensity (i.e. cycling) to elicit favourable training stimuli, i.e., acute responses in main outcome measures of muscular activation, muscular deoxygenation, and secondary outcome measures of heart rate (HR), blood lactate (bLa), subjective ratings of perceived exertion and discomfort?; (ii) How does BFR + HIIT compare with traditional HIIT at a similar or higher exercise intensity in terms of these acute responses?

The hypotheses for this study are: (i) BFR increases muscular deoxygenation, muscular activation when HIIT exercise is of the same intensity, (ii) however, comparing between a lower BFR + HIIT exercise intensity (e.g. 80% V̇O2max) and higher HIIT exercise intensity (e.g. 100% V̇O2max), muscular deoxygenation and activation will be similar but HR will be lower in the BFR + HIIT condition.

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Acute Responses to High-intensity Interval Exercise (HIIE) and Blood Flow Restriction (BFR)
Actual Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: HIIT Control

High intensity interval cycling

Other: Active Comparator: HIIT Control
Complete 3 sets of five repetitions of 30 seconds cycling at 100% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets.

Experimental: HIIT + BFR between cycling sets

High intensity interval cycling with blood flow restriction applied between sets of cycling

Other: Experimental: HIIT + BFR between cycling sets
Complete 3 sets of five repetitions of 30 seconds cycling at 100% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied for 2 minutes during the passive rest at 80% of limb occlusion pressure.

Experimental: HIIT + BFR moderate occlusion during cycling

High intensity interval cycling with moderate blood flow restriction applied during cycling

Other: Experimental: HIIT + BFR moderate occlusion during cycling
Complete 3 sets of five repetitions of 30 seconds cycling at 70% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied during and between exercise repetitions at 50% of limb occlusion pressure and deflated during passive rest periods.

Experimental: HIIT + BFR high occlusion during cycling

High intensity interval cycling with high blood flow restriction applied during cycling

Other: Experimental: HIIT + BFR high occlusion during cycling
Complete 3 sets of five repetitions of 30 seconds cycling at 70% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied during and between exercise repetitions at 80% of limb occlusion pressure and deflated during passive rest periods.

Outcome Measures

Primary Outcome Measures

  1. Heart rate [Measured and compared between each acute arm (condition)]

  2. Blood lactate concentration [Measured and compared between each acute arm (condition)]

  3. Muscle activation [Measured and compared between each acute arm (condition)]

    Surface electromyography of the vastus lateralis and biceps femoris muscles to determine electrical activity of the motor units (physiological parameter)

  4. Muscle oxygenation [Measured and compared between each acute arm (condition)]

    Near infra-red spectroscopy to examine regional tissue (the vastus lateralis muscle) oxygenation i.e, the percentage of haemoglobin and deoxyhaemoglobin (physiological parameter)

Secondary Outcome Measures

  1. Rating of perceived exertion [Measured and compared between each acute arm (condition)]

    Borg Rating of Perceived Exertion scale 6-20 (6 = no exertion at all; 20 = maximal exertion)

  2. Exertion and Pain scale [Measured and compared between each acute arm (condition)]

    Borg Category-Ratio (CR) 10 scale (0 = No exertion at all; 10 = Maximal)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male

  • Age: 18-40 years

  • Competed in competitive varsity sports (endurance, tennis, badminton, squash, football, basketball, etc.) at the varsity/club level

  • Actively training for at least 2 sessions (1 - 1.5h) per week

  • Healthy (free from illnesses) and no musculoskeletal injuries for the past 6 months

  • No history of cardiometabolic, vascular diseases or similar conditions (high blood pressure, peripheral vascular diseases, heart diseases, metabolic syndrome, diabetes, stroke, etc.).

  • Pass pre-participation health screening tests - Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and Australian Institute of Sport (AIS) Blood Flow Restriction (BFR) pre-screening questionnaire (no history of any risk factors).

  • Maximal oxygen uptake (VO2max) of ≥40mmol/min/kg during a maximal aerobic cycling test.

  • Non-smoker

  • Drink alcohol less than 3 times each week and less than 3 drinks each time

Exclusion Criteria:
  • Any diagnosed form of cardiometabolic disease (CVD, diabetes, metabolic syndrome, hypertension)

  • Any symptoms contraindication of exercise testing (eg chest pains)

  • Any balance or dizziness problems

  • Any chronic medical conditions (whether medicated or not)

  • Any bone joint problems

  • Any Physician diagnosed contraindications to exercise

Contacts and Locations

Locations

Site City State Country Postal Code
1 Human Bioenergetics Laboratory, National Institute of Education, Nanyang Technological University Singapore Singapore 637616

Sponsors and Collaborators

  • Nanyang Technological University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stephen Burns, Associate Professor, Nanyang Technological University
ClinicalTrials.gov Identifier:
NCT05835544
Other Study ID Numbers:
  • IRB-2022-135
First Posted:
Apr 28, 2023
Last Update Posted:
Apr 28, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Stephen Burns, Associate Professor, Nanyang Technological University

Study Results

No Results Posted as of Apr 28, 2023